Tamarack Advisers LP Sells 30,000 Shares of HCA Holdings, Inc. (HCA)
Tamarack Advisers LP lowered its stake in HCA Holdings, Inc. (NYSE:HCA) by 37.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 50,000 shares of the company’s stock after selling 30,000 shares during the period. HCA Holdings accounts for approximately 2.5% of Tamarack Advisers LP’s holdings, making the stock its 18th largest position. Tamarack Advisers LP’s holdings in HCA Holdings were worth $4,360,000 at the end of the most recent reporting period.
Several other hedge funds have also recently made changes to their positions in the company. Janney Montgomery Scott LLC raised its position in HCA Holdings by 0.4% in the second quarter. Janney Montgomery Scott LLC now owns 3,174 shares of the company’s stock valued at $277,000 after buying an additional 14 shares during the period. Advisor Partners LLC raised its position in HCA Holdings by 0.3% in the second quarter. Advisor Partners LLC now owns 4,732 shares of the company’s stock worth $413,000 after buying an additional 14 shares during the last quarter. Wetherby Asset Management Inc. raised its position in HCA Holdings by 0.6% in the second quarter. Wetherby Asset Management Inc. now owns 4,232 shares of the company’s stock worth $369,000 after buying an additional 25 shares during the last quarter. Boston Advisors LLC raised its position in HCA Holdings by 0.6% in the first quarter. Boston Advisors LLC now owns 6,212 shares of the company’s stock worth $553,000 after buying an additional 37 shares during the last quarter. Finally, Capstone Asset Management Co. raised its position in HCA Holdings by 1.1% in the first quarter. Capstone Asset Management Co. now owns 7,083 shares of the company’s stock worth $630,000 after buying an additional 80 shares during the last quarter. Institutional investors and hedge funds own 75.69% of the company’s stock.
HCA Holdings, Inc. (NYSE HCA) opened at 79.51 on Friday. The firm has a market capitalization of $28.72 billion, a P/E ratio of 10.66 and a beta of 0.67. The stock’s 50 day moving average is $81.48 and its 200-day moving average is $84.16. HCA Holdings, Inc. has a 1-year low of $67.00 and a 1-year high of $91.03.
HCA Holdings (NYSE:HCA) last released its earnings results on Tuesday, July 25th. The company reported $1.75 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.80 by $0.05. The business had revenue of $10.73 billion during the quarter, compared to analyst estimates of $10.76 billion. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.66 earnings per share. Analysts forecast that HCA Holdings, Inc. will post $7.18 EPS for the current year.
TRADEMARK VIOLATION WARNING: This report was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/26/tamarack-advisers-lp-sells-30000-shares-of-hca-holdings-inc-hca.html.
A number of equities analysts have recently commented on HCA shares. Morgan Stanley started coverage on HCA Holdings in a research note on Tuesday, June 6th. They issued an “equal weight” rating and a $90.00 price objective on the stock. Leerink Swann upgraded HCA Holdings from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $92.00 to $100.00 in a research note on Tuesday, June 6th. BidaskClub upgraded HCA Holdings from a “strong sell” rating to a “sell” rating in a research note on Tuesday, June 13th. Argus initiated coverage on HCA Holdings in a research report on Wednesday, June 28th. They set a “buy” rating and a $100.00 target price on the stock. Finally, Zacks Investment Research raised HCA Holdings from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a research report on Thursday, July 13th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $92.88.
In related news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction on Monday, July 17th. The stock was sold at an average price of $86.44, for a total value of $185,846.00. Following the completion of the transaction, the insider now directly owns 12,363 shares in the company, valued at $1,068,657.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jonathan B. Perlin sold 71,063 shares of the company’s stock in a transaction on Thursday, June 22nd. The shares were sold at an average price of $86.00, for a total value of $6,111,418.00. The disclosure for this sale can be found here. Insiders sold 77,513 shares of company stock valued at $6,651,455 over the last quarter. Insiders own 2.90% of the company’s stock.
About HCA Holdings
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.